Skip to main content
Erschienen in:

02.10.2023 | Research and Reporting Methods

A Dose of Reality About Dose–Response Relationships

verfasst von: Donald A. Redelmeier, MD FRCPC, Jonathan S. Zipursky, MD PhD FRCPC

Erschienen in: Journal of General Internal Medicine | Ausgabe 16/2023

Einloggen, um Zugang zu erhalten

Abstract

Observational research can be strengthened by examining potential dose–response relationships that correlate a clinical intervention with a patient outcome. Despite being a classic criterion for establishing causality, dose–response testing can be difficult to interpret in clinical medicine due to multiple diverse pitfalls. This review introduces a cautionary framework for investigators considering dose–response relationships in observational research to support evidence-based medicine. Each pitfall is illustrated with a specific example relevant when analyzing a dose–response relationship. Several pitfalls stem from faulty interpretation including confounding by indication and fallible range selection. Additional pitfalls relate to improper analysis including fitting a nonlinear model and misclassification error. Further pitfalls arise in special situations including subjective self-report and artifacts from survival bias. These caveats are common sources of misunderstanding in analyses that examine the link between varying exposures and the intensity of clinical outcomes. Awareness of specific pitfalls, we suggest, might help advance the conduct, application, and translation of dose–response relationships in observational research to inform evidence-based medical care.
Literatur
1.
Zurück zum Zitat Doll R, Hill AB. Lung cancer and other causes of death in relation to smoking; a second report on the mortality of British doctors. BMJ. 1956;2(5001):1071-81.CrossRefPubMedPubMedCentral Doll R, Hill AB. Lung cancer and other causes of death in relation to smoking; a second report on the mortality of British doctors. BMJ. 1956;2(5001):1071-81.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Bradford Hill A. The environment and disease: association or causation? Proceedings of the Royal Society of Medicine. 1965;58:295-300. Bradford Hill A. The environment and disease: association or causation? Proceedings of the Royal Society of Medicine. 1965;58:295-300.
3.
Zurück zum Zitat Guyatt GH, Oxman AD, Sultan S, Glasziou P, Akl EA, Alonso-Coello P, Atkins D, Kunz R, Brozek J, Montori V, Jaeschke R, Rind D, Dahm P, Meerpohl J, Vist G, Berliner E, Norris S, Falck-Ytter Y, Murad MH, Schünemann HJ, GRADE Working Group. GRADE guidelines: 9. Rating up the quality of evidence. J Clin Epidemiol. 2011;64(12):1311-6.CrossRefPubMed Guyatt GH, Oxman AD, Sultan S, Glasziou P, Akl EA, Alonso-Coello P, Atkins D, Kunz R, Brozek J, Montori V, Jaeschke R, Rind D, Dahm P, Meerpohl J, Vist G, Berliner E, Norris S, Falck-Ytter Y, Murad MH, Schünemann HJ, GRADE Working Group. GRADE guidelines: 9. Rating up the quality of evidence. J Clin Epidemiol. 2011;64(12):1311-6.CrossRefPubMed
5.
Zurück zum Zitat de Craen AJ, Moerman DE, Heisterkamp SH, Tytgat GN, Tijssen JG, Kleijnen J. Placebo effect in the treatment of duodenal ulcer. Br J Clin Pharmacol. 1999;48(6):853-60.CrossRefPubMedPubMedCentral de Craen AJ, Moerman DE, Heisterkamp SH, Tytgat GN, Tijssen JG, Kleijnen J. Placebo effect in the treatment of duodenal ulcer. Br J Clin Pharmacol. 1999;48(6):853-60.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Espay AJ, Norris MM, Eliassen JC, Dwivedi A, Smith MS, Banks C, Allendorfer JB, Lang AE, Fleck DE, Linke MJ, Szaflarski JP. Placebo effect of medication cost in Parkinson disease: a randomized double-blind study. Neurology. 2015;84(8):794-802.CrossRefPubMedPubMedCentral Espay AJ, Norris MM, Eliassen JC, Dwivedi A, Smith MS, Banks C, Allendorfer JB, Lang AE, Fleck DE, Linke MJ, Szaflarski JP. Placebo effect of medication cost in Parkinson disease: a randomized double-blind study. Neurology. 2015;84(8):794-802.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Malizia BA, Hacker MR, Penzias AS. Cumulative live-birth rates after in vitro fertilization. N Engl J Med. 2009;360(3):236-43.CrossRefPubMed Malizia BA, Hacker MR, Penzias AS. Cumulative live-birth rates after in vitro fertilization. N Engl J Med. 2009;360(3):236-43.CrossRefPubMed
8.
Zurück zum Zitat Smith ADAC, Tilling K, Nelson SM, Lawlor DA. Live-birth rate associated with repeat in vitro fertilization treatment cycles. JAMA. 2015;314(24):2654-2662.CrossRefPubMedPubMedCentral Smith ADAC, Tilling K, Nelson SM, Lawlor DA. Live-birth rate associated with repeat in vitro fertilization treatment cycles. JAMA. 2015;314(24):2654-2662.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Payet C, Polazzi S, Obadia JF, Armoiry X, Labarère J, Rabilloud M, Duclos A. High-dimensional propensity scores improved the control of indication bias in surgical comparative effectiveness studies. J Clin Epidemiol. 2021;130:78-86.CrossRefPubMed Payet C, Polazzi S, Obadia JF, Armoiry X, Labarère J, Rabilloud M, Duclos A. High-dimensional propensity scores improved the control of indication bias in surgical comparative effectiveness studies. J Clin Epidemiol. 2021;130:78-86.CrossRefPubMed
10.
Zurück zum Zitat McAlister FA, Wiebe N, Ezekowitz JA, Leung AA, Armstrong PW. Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure. Ann Intern Med. 2009;150(11):784-94.CrossRefPubMed McAlister FA, Wiebe N, Ezekowitz JA, Leung AA, Armstrong PW. Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure. Ann Intern Med. 2009;150(11):784-94.CrossRefPubMed
11.
Zurück zum Zitat Kushner PR, Peura DA. Review of proton pump inhibitors for the initial treatment of heartburn: is there a dose ceiling effect? Adv Ther. 2011;28(5):367-88.CrossRefPubMed Kushner PR, Peura DA. Review of proton pump inhibitors for the initial treatment of heartburn: is there a dose ceiling effect? Adv Ther. 2011;28(5):367-88.CrossRefPubMed
12.
Zurück zum Zitat Gyawali R, Toomey M, Stapleton F, Zangerl B, Dillon L, Ho KC, Keay L, Alkhawajah SMM, Liew G, Jalbert I. Systematic review of diabetic eye disease practice guidelines: more applicability, transparency and development rigor are needed. J Clin Epidemiol. 2021;140:56-68.CrossRefPubMed Gyawali R, Toomey M, Stapleton F, Zangerl B, Dillon L, Ho KC, Keay L, Alkhawajah SMM, Liew G, Jalbert I. Systematic review of diabetic eye disease practice guidelines: more applicability, transparency and development rigor are needed. J Clin Epidemiol. 2021;140:56-68.CrossRefPubMed
13.
Zurück zum Zitat Santaguida P, Oremus M, Walker K, Wishart LR, Siegel KL, Raina P. Systematic reviews identify important methodological flaws in stroke rehabilitation therapy primary studies: review of reviews. J Clin Epidemiol. 2012;65(4):358-67.CrossRefPubMed Santaguida P, Oremus M, Walker K, Wishart LR, Siegel KL, Raina P. Systematic reviews identify important methodological flaws in stroke rehabilitation therapy primary studies: review of reviews. J Clin Epidemiol. 2012;65(4):358-67.CrossRefPubMed
14.
Zurück zum Zitat Armstrong BG. The effects of measurement errors on relative risk regressions. American Journal of Epidemiology. 1990;132(6):1176-84.CrossRefPubMed Armstrong BG. The effects of measurement errors on relative risk regressions. American Journal of Epidemiology. 1990;132(6):1176-84.CrossRefPubMed
15.
Zurück zum Zitat DeLean A, Munson PJ, Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. American Journal of Physiology-Endocrinology and Metabolism. 1978;235(2):E97-102.CrossRef DeLean A, Munson PJ, Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. American Journal of Physiology-Endocrinology and Metabolism. 1978;235(2):E97-102.CrossRef
16.
Zurück zum Zitat Zhang F, Chiu Y, Ensor J, Mohamed MO, Peat G, Mamas MA. Elixhauser outperformed Charlson comorbidity index in prognostic value after ACS: insights from a national registry. J Clin Epidemiol. 2022;141:26-35.CrossRefPubMed Zhang F, Chiu Y, Ensor J, Mohamed MO, Peat G, Mamas MA. Elixhauser outperformed Charlson comorbidity index in prognostic value after ACS: insights from a national registry. J Clin Epidemiol. 2022;141:26-35.CrossRefPubMed
17.
Zurück zum Zitat Gompertz B. On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies. Philosophical Transactions of the Royal Society of London B: Biological Sciences. 1825;182:513–85. Gompertz B. On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies. Philosophical Transactions of the Royal Society of London B: Biological Sciences. 1825;182:513–85.
18.
Zurück zum Zitat Makeham W. On the integral of Gompertz's function for expressing the values of sums depending upon the contingency of life. Journal of the Institute of Actuaries. 1873;17(5):305-27.CrossRef Makeham W. On the integral of Gompertz's function for expressing the values of sums depending upon the contingency of life. Journal of the Institute of Actuaries. 1873;17(5):305-27.CrossRef
19.
Zurück zum Zitat Tjørve KMC, Tjørve E. The use of Gompertz models in growth analyses, and new Gompertz-model approach: An addition to the Unified-Richards family. PLoS One. 2017;12(6):e0178691.CrossRefPubMedPubMedCentral Tjørve KMC, Tjørve E. The use of Gompertz models in growth analyses, and new Gompertz-model approach: An addition to the Unified-Richards family. PLoS One. 2017;12(6):e0178691.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Choudhry NK, Shrank WH. Implementing randomized effectiveness trials in large insurance systems. J Clin Epidemiol. 2013;66(8 Suppl):S5-11.CrossRefPubMed Choudhry NK, Shrank WH. Implementing randomized effectiveness trials in large insurance systems. J Clin Epidemiol. 2013;66(8 Suppl):S5-11.CrossRefPubMed
21.
Zurück zum Zitat van Walraven C, McCudden C, Austin PC. Imputing missing laboratory results may return erroneous values because they are not missing at random. J Clin Epidemiol. 2022 15;154:65-74. van Walraven C, McCudden C, Austin PC. Imputing missing laboratory results may return erroneous values because they are not missing at random. J Clin Epidemiol. 2022 15;154:65-74.
22.
Zurück zum Zitat Redelmeier DA, Dickinson VM. Determining whether a patient is feeling better: pitfalls from the science of human perception. J Gen Intern Med. 2011;26(8):900-6.CrossRefPubMedPubMedCentral Redelmeier DA, Dickinson VM. Determining whether a patient is feeling better: pitfalls from the science of human perception. J Gen Intern Med. 2011;26(8):900-6.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Keating C. Sex differences precipitating anorexia nervosa in females: the estrogen paradox and a novel framework for targeting sex-specific neurocircuits and behavior. Curr Top Behav Neurosci. 2011;8:189-207.CrossRefPubMed Keating C. Sex differences precipitating anorexia nervosa in females: the estrogen paradox and a novel framework for targeting sex-specific neurocircuits and behavior. Curr Top Behav Neurosci. 2011;8:189-207.CrossRefPubMed
24.
Zurück zum Zitat Wilson SE. Clinical practice. Use of lasers for vision correction of nearsightedness and farsightedness. N Engl J Med. 2004;351(5):470-5.CrossRefPubMed Wilson SE. Clinical practice. Use of lasers for vision correction of nearsightedness and farsightedness. N Engl J Med. 2004;351(5):470-5.CrossRefPubMed
25.
Zurück zum Zitat Oude Groeniger J, Kamphuis CB, Mackenbach JP, van Lenthe FJ. Repeatedly measured material and behavioral factors changed the explanation of socioeconomic inequalities in all-cause mortality. J Clin Epidemiol. 2017;91:137-145.CrossRefPubMed Oude Groeniger J, Kamphuis CB, Mackenbach JP, van Lenthe FJ. Repeatedly measured material and behavioral factors changed the explanation of socioeconomic inequalities in all-cause mortality. J Clin Epidemiol. 2017;91:137-145.CrossRefPubMed
26.
27.
Zurück zum Zitat Yuen J, Persson I, Bergkvist L, Hoover R, Schairer C, Adami HO. Hormone replacement therapy and breast cancer mortality in Swedish women: results after adjustment for 'healthy drug-user' effect. Cancer Causes Control. 1993;4(4):369-74.CrossRefPubMed Yuen J, Persson I, Bergkvist L, Hoover R, Schairer C, Adami HO. Hormone replacement therapy and breast cancer mortality in Swedish women: results after adjustment for 'healthy drug-user' effect. Cancer Causes Control. 1993;4(4):369-74.CrossRefPubMed
28.
Zurück zum Zitat Kristman VL, Borg J, Godbolt AK, Salmi LR, Cancelliere C, Carroll LJ, Holm LW, Nygren-de Boussard C, Hartvigsen J, Abara U, Donovan J, Cassidy JD. Methodological issues and research recommendations for prognosis after mild traumatic brain injury: results of the International Collaboration on Mild Traumatic Brain Injury Prognosis. Arch Phys Med Rehabil. 2014;95(3 Suppl):S265-77.CrossRefPubMed Kristman VL, Borg J, Godbolt AK, Salmi LR, Cancelliere C, Carroll LJ, Holm LW, Nygren-de Boussard C, Hartvigsen J, Abara U, Donovan J, Cassidy JD. Methodological issues and research recommendations for prognosis after mild traumatic brain injury: results of the International Collaboration on Mild Traumatic Brain Injury Prognosis. Arch Phys Med Rehabil. 2014;95(3 Suppl):S265-77.CrossRefPubMed
29.
Zurück zum Zitat Grashow RG, Roberts AL, Zafonte R, Pascual-Leone A, Taylor H, Baggish A, Nadler L, Courtney TK, Connor A, Weisskopf MG. Defining exposures in professional football: professional American-style football players as an occupational cohort. Orthop J Sports Med. 2019;7(2):2325967119829212.CrossRefPubMedPubMedCentral Grashow RG, Roberts AL, Zafonte R, Pascual-Leone A, Taylor H, Baggish A, Nadler L, Courtney TK, Connor A, Weisskopf MG. Defining exposures in professional football: professional American-style football players as an occupational cohort. Orthop J Sports Med. 2019;7(2):2325967119829212.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Daugherty J; DePadilla L, Sarmiento K, Breiding M. Self-reported lifetime concussion among adults: comparison of 3 different survey questions. Journal of Head Trauma Rehabilitation 2020;35(2):E136-E143.CrossRefPubMedPubMedCentral Daugherty J; DePadilla L, Sarmiento K, Breiding M. Self-reported lifetime concussion among adults: comparison of 3 different survey questions. Journal of Head Trauma Rehabilitation 2020;35(2):E136-E143.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Laurer HL, Bareyre FM, Lee VMYC, Trojanowski JQ, Longhi L, Hoover R, Saatman KE, Raghupathi R, Hoshino S, Grady MS, McIntosh TK. Mild head injury increasing the brain’s vulnerability to a second concussive impact. J Neurosurg. 2001;95(5):859-870.CrossRefPubMed Laurer HL, Bareyre FM, Lee VMYC, Trojanowski JQ, Longhi L, Hoover R, Saatman KE, Raghupathi R, Hoshino S, Grady MS, McIntosh TK. Mild head injury increasing the brain’s vulnerability to a second concussive impact. J Neurosurg. 2001;95(5):859-870.CrossRefPubMed
32.
Zurück zum Zitat Matthewman J, Tadrous M, Mansfield KE, Thiruchelvam D, Redelmeier DA, Cheung AM, Lega IC, Prieto-Alhambra D, Cunliffe LA, Mulick A, Henderson A, Langan SM, Drucker AM. Association of different prescribing patterns for oral corticosteroids with fracture preventive care among older adults in the UK and Ontario. JAMA Dermatol. 2023:e232495. Matthewman J, Tadrous M, Mansfield KE, Thiruchelvam D, Redelmeier DA, Cheung AM, Lega IC, Prieto-Alhambra D, Cunliffe LA, Mulick A, Henderson A, Langan SM, Drucker AM. Association of different prescribing patterns for oral corticosteroids with fracture preventive care among older adults in the UK and Ontario. JAMA Dermatol. 2023:e232495.
33.
Zurück zum Zitat Day NE. The assessment of lead time and length bias in the evaluation of screening programmes. Maturitas. 1985;7(1):51-8.CrossRefPubMed Day NE. The assessment of lead time and length bias in the evaluation of screening programmes. Maturitas. 1985;7(1):51-8.CrossRefPubMed
34.
Zurück zum Zitat Staats BR, Milkman KL, Fox CR. The team scaling fallacy: Underestimating the declining efficiency of larger teams. Organizational Behavior and Human Decision Processes. 2012;118(2):132-42.CrossRef Staats BR, Milkman KL, Fox CR. The team scaling fallacy: Underestimating the declining efficiency of larger teams. Organizational Behavior and Human Decision Processes. 2012;118(2):132-42.CrossRef
Metadaten
Titel
A Dose of Reality About Dose–Response Relationships
verfasst von
Donald A. Redelmeier, MD FRCPC
Jonathan S. Zipursky, MD PhD FRCPC
Publikationsdatum
02.10.2023
Verlag
Springer International Publishing
Erschienen in
Journal of General Internal Medicine / Ausgabe 16/2023
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-023-08395-x

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

GLP-1-Agonist erfolgreich gegen metabolische Fettleber

Semaglutid bringt eine metabolische Steatohepatitis bei rund zwei Dritteln der Betroffenen in Remission. Ein Drittel zeigt zudem eine geringere Fibrose. Darauf weisen Ergebnisse einer Placebo-kontrollierten Phase-3-Studie.

Was tun bei grenzwertig erhöhtem Serumkreatinin?

Ein Serumkreatinin von 1,4 mg/dl kann zwar banale extrarenale Ursachen haben, aber u. U. auch eine schwere Nierenerkrankung anzeigen. Die Urindiagnostik ist deswegen ein Muss, wie Prof. Martin Hausberg beim Kongress der DGIM darlegte.

Weniger Statinverordnungen bei hohen HDL-Werten

Offenbar haftet dem HDL-Cholesterin (HDL-C) immer noch der Ruf des „guten“ Cholesterins an. Das kann bei hohen HDL-C-Werten zu falscher Zurückhaltung bei einer Statintherapie führen.

Große Versorgungslücken bei Menschen mit Störungen der Intelligenzentwicklung

Bei ihrer Tätigkeit mit Menschen, die eine Störung der intellektuellen Entwicklung aufweisen, war Prof. Dr. Tanja Sappok aus Bielefeld zutiefst erschüttert, wie häufig Tumorerkrankungen erst in weit fortgeschrittenen Stadien erkannt werden. Auf dem diesjährigen Kongress der Deutschen Gesellschaft für Innere Medizin (DGIM) berichtete sie von ihren Erfahrungen.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.